- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery
Authors
Keywords
Sorafenib, Solid lipid nanoparticles, Nucleolipids, Hepatocarcinoma, Breast carcinoma, Luminal B
Journal
Nanoscale Research Letters
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-11
DOI
10.1186/s11671-017-2420-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma
- (2016) Wooram Park et al. ACS Applied Materials & Interfaces
- Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis
- (2016) Khalid Oumzil et al. BIOCONJUGATE CHEMISTRY
- Intracellular interactions of electrostatically mediated layer-by-layer assembled polyelectrolytes based sorafenib nanoparticles in oral cancer cells
- (2016) Radhika Poojari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma
- (2015) Raj Kumar Thapa et al. ACS Applied Materials & Interfaces
- Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
- (2015) Alexandra Correia et al. ACS Applied Materials & Interfaces
- Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study
- (2015) D. Jäger et al. Clinical Genitourinary Cancer
- Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells
- (2015) Maria Luisa Bondì et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma
- (2015) Haiqiang Cao et al. MOLECULAR PHARMACEUTICS
- Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma
- (2014) Giridharan Loghanathan Malarvizhi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Quantum Dot Lipid Oligonucleotide Bioconjugates: Toward a New Anti-MicroRNA Nanoplatform
- (2013) Ahissan Aimé et al. BIOCONJUGATE CHEMISTRY
- Efficient delivery of therapeutic small nucleic acids to prostate cancer cells using ketal nucleoside lipid nanoparticles
- (2013) Delphine Luvino et al. JOURNAL OF CONTROLLED RELEASE
- Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles
- (2012) Hong Zhang et al. International Journal of Nanomedicine
- Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer
- (2012) Do Kim et al. Nanoscale Research Letters
- Nucleoside–Lipid-Based Nanoparticles for Cisplatin Delivery
- (2011) Salim Khiati et al. ACS Nano
- Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat
- (2011) Xue-qing Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anionic Nucleotide−Lipids forIn VitroDNA Transfection
- (2009) Salim Khiati et al. BIOCONJUGATE CHEMISTRY
- Nucleoside-based lipids at work: From supramolecular assemblies to biological applications
- (2008) Philippe Barthélemy COMPTES RENDUS CHIMIE
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started